Children's Hospital of Philadelphia Foundation's Net Worth

$506 Million

Estimate Recalculated Feb 7, 2024 04:03PM EST

Who is Children's Hospital of Philadelphia Foundation?

Children's Hospital of Philadelphia Foundation has an estimated net worth of $506 Million. This is based on reported shares across multiple companies, which include Spark Therapeutics, Inc., and Aevi Genomic Medicine, Inc..

SEC CIK

Children's Hospital of Philadelphia Foundation's CIK is 0001632060

Past Insider Trading and Trends

2015 was Children's Hospital of Philadelphia Foundation's most active year for acquiring shares with 4 total transactions. Children's Hospital of Philadelphia Foundation's most active month to acquire stocks was the month of January. 2015 was Children's Hospital of Philadelphia Foundation's most active year for disposing of shares, totalling 6 transactions. Children's Hospital of Philadelphia Foundation's most active month to dispose stocks was the month of January. 2018 saw Children's Hospital of Philadelphia Foundation paying a total of $2,448,979.20 for 2,551,020 shares, this is the most they've acquired in one year. In 2019 Children's Hospital of Philadelphia Foundation cashed out on 2,000,000 shares for a total of $226,000,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Spark Therapeutics, Inc. No price found

Investor

Children's Hospital of Philadelphia Foundation owns 1,954,957 units of Common Stock. From 2015 to 2019 Children's Hospital of Philadelphia Foundation acquired a total of 3,982,833 shares in Spark Therapeutics, Inc. at a cost of $3,103,070.00, Children's also disposed a total of 6,971,505 shares of Spark Therapeutics, Inc. equalling to $511,086,690.90.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-50.57%
-2.00M
$113.00
-$226,000,000.00
1.95M
Feb 27
Form 4
+0.67%
26.25K
$30.59
$803,070.00
3.95M
Sep 27
Form 4
-20.29%
-1.00M
$84.63
-$84,630,000.00
3.93M
Sep 21
Form 4
-14.56%
-840.00K
$56.27
-$47,266,800.00
4.93M
May 11
Form 4
-14.77%
-1.00M
$60.90
-$60,900,000.00
5.77M
Aug 16
Form 4
-12.87%
-1.00M
$42.30
-$42,300,000.00
6.77M
Jun 20
Form 4
-1.66%
-131.50K
$44.18
-$5,809,890.90
7.77M
Dec 28
Form 4
-11.24%
-1.00M
$44.18
-$44,180,000.00
7.9M
Dec 21
Form 4
+80.03%
3.96M
$23.00
8.9M
Feb 4
Form 4
0
0
Jan 30
Form 3
0
0
No matching records found

Aevi Genomic Medicine, Inc. No price found

Investor

Children's Hospital of Philadelphia Foundation used to own units in Common Stock but no longer holds any shares there. From 2017 to 2020 Children's Hospital of Philadelphia Foundation acquired a total of 41,407,911 shares in Aevi Genomic Medicine, Inc. at a cost of $2,448,979.20, Children's also disposed a total of 57,280,927 shares of Aevi Genomic Medicine, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-18.42M
0
Feb 3
Form 4
+16.07%
2.55M
$0.96
$2,448,979.20
18.42M
Aug 15
Form 3
0
0
No matching records found